News Focus
News Focus
Followers 9
Posts 1397
Boards Moderated 0
Alias Born 05/23/2008

Re: ArchieK post# 318216

Monday, 11/13/2017 5:18:30 PM

Monday, November 13, 2017 5:18:30 PM

Post# of 347009
Peregrine put this release out today, were they just kidding?

Not much to dissect here is there?


About Peregrine Pharmaceuticals, Inc.
Peregrine Pharmaceuticals, Inc. is a company transitioning from an R&D focused business to a pure play contract development and manufacturing organization (CDMO). Peregrine's in-house CDMO services, including cGMP manufacturing and development capabilities, are provided through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com).

The company is pursuing to license or sell its proprietary R&D assets, including its lead immunotherapy candidate, bavituximab, which is currently being evaluated in clinical trials in combination with immune stimulating therapies for the treatment of various cancers. For more information, please visit www.peregrineinc.com.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y